Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -220,662 | -208,383 | -148,839 | -142,096 | -142,094 |
| Depreciation Amortization | 7,716 | 6,565 | 7,422 | 8,458 | 5,658 |
| Income taxes - deferred | -185 | -986 | -268 | -72 | -1,344 |
| Accounts payable and accrued liabilities | 1,590 | -509 | 22 | -1,816 | 1,439 |
| Other Working Capital | -23,655 | 292 | 536 | 4,138 | 1,410 |
| Other Operating Activity | 28,925 | 57,434 | 28,819 | 13,527 | 17,173 |
| Operating Cash Flow | $-206,271 | $-145,587 | $-112,308 | $-117,861 | $-117,758 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -359,733 | N/A | N/A | N/A | N/A |
| PPE Investments | -22,075 | -10,986 | -10,841 | -8,857 | -14,681 |
| Purchase Sale Intangibles | -12,744 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -12,744 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-394,552 | $-10,986 | $-10,841 | $-8,857 | $-14,681 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 550,579 | 27 | 163,971 | 246,025 | 80,212 |
| Other Financing Activity | 38,975 | -910 | 59,639 | 38,038 | -5,797 |
| Financing Cash Flow | $589,554 | $-883 | $223,610 | $284,063 | $74,415 |
| Exchange Rate Effect | -261 | 15,030 | -28,376 | -754 | 679 |
| Beginning Cash Position | 240,335 | 382,761 | 310,676 | 154,085 | 211,430 |
| End Cash Position | 228,805 | 240,335 | 382,761 | 310,676 | 154,085 |
| Net Cash Flow | $-11,530 | $-142,426 | $72,085 | $156,591 | $-57,345 |
| Free Cash Flow | |||||
| Operating Cash Flow | -206,271 | -145,587 | -112,308 | -117,861 | -117,758 |
| Capital Expenditure | -22,075 | -10,986 | -10,841 | -8,857 | -14,681 |
| Free Cash Flow | -228,346 | -156,573 | -123,149 | -126,718 | -132,439 |